Skip to main content

Market Overview

23 Healthcare Stocks Moving In Thursday's Pre-Market Session

Share:

Gainers

  • TRACON Pharmaceuticals, Inc. (NASDAQ: TCON) stock rose 18.5% to $0.64 during Thursday's pre-market session. The market cap stands at $74.3 million. The most recent rating by H.C. Wainwright, on August 29, is at Buy, with a price target of $2.00.
  • Plus Therapeutics, Inc. (NASDAQ: PSTV) shares surged 14.3% to $22.00. The market cap seems to be at $226.6 million.
  • Edap TMS, Inc. (NASDAQ: EDAP) shares moved upwards by 11.1% to $3.80. The market cap stands at $86.9 million.
  • Otonomy, Inc. (NASDAQ: OTIC) shares rose 7.9% to $2.33. The market cap seems to be at $75.9 million. The most recent rating by H.C. Wainwright, on August 29, is at Buy, with a price target of $8.00.
  • Cancer Genetics, Inc. (NASDAQ: CGIX) stock rose 7.8% to $0.09. The market cap seems to be at $37.0 million.
  • Acasti Pharma, Inc. (NASDAQ: ACST) shares surged 7.6% to $1.84. The market value of their outstanding shares is at $25.6 million. The most recent rating by Oppenheimer, on July 18, is at Outperform, with a price target of $7.00.
  • Soligenix, Inc. (NASDAQ: SNGX) stock increased by 6.4% to $1.17. The market cap stands at $16.6 million.
  • Kitov Pharma, Inc. (NASDAQ: KTOV) stock increased by 5.1% to $0.75. The market value of their outstanding shares is at $28.6 million.
  • Histogenics, Inc. (NASDAQ: HSGX) stock surged 4.4% to $0.24. The market cap seems to be at $52.8 million.
  • Esperion Therapeutics, Inc. (NASDAQ: ESPR) stock rose 4.2% to $37.50. The market cap stands at $335.0 million.
  • Therapix Biosciences, Inc. (NASDAQ: TRPX) stock rose 3.7% to $2.50. The market cap stands at $8.3 million.
  • Radius Health, Inc. (NASDAQ: RDUS) stock surged 3.2% to $25.70. The market cap stands at $1.3 billion. The most recent rating by Citigroup, on August 29, is at Buy, with a price target of $40.00.
  • Aphria, Inc. (NYSE: APHA) stock increased by 3.0% to $6.40. According to the most recent rating by CIBC, on July 26, the current rating is at Underperformer.
  • Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) stock moved upwards by 2.9% to $10.85.
  • Teva Pharmaceutical Indus, Inc. (NYSE: TEVA) stock surged 2.7% to $7.13. The market cap stands at $7.3 billion. The most recent rating by BMO Capital, on August 09, is at Market Perform, with a price target of $9.00.
  • DBV Technologies, Inc. (NASDAQ: DBVT) stock rose 2.6% to $9.12. The most recent rating by Goldman Sachs, on June 17, is at Buy, with a price target of $14.00.
  • CannTrust Holdings, Inc. (NYSE: CTST) stock moved upwards by 2.4% to $1.70. The market cap stands at $320.7 million.
  • Nabriva Therapeutics, Inc. (NASDAQ: NBRV) shares rose 2.4% to $2.15. The market cap seems to be at $176.8 million.

 

Losers

  • Solid Biosciences, Inc. (NASDAQ: SLDB) stock fell 8.7% to $8.30 during Thursday's pre-market session. The market cap seems to be at $321.5 million. The most recent rating by Citigroup, on August 29, is at Sell, with a price target of $6.00.
  • DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) shares fell 6.5% to $0.62.
  • VIVUS, Inc. (NASDAQ: VVUS) stock plummeted 4.7% to $4.04. The market value of their outstanding shares is at $23.7 million.
  • T2 Biosystems, Inc. (NASDAQ: TTOO) stock decreased by 3.6% to $1.35. The market cap stands at $209.3 million. The most recent rating by Alliance Global Partners, on August 01, is at Neutral, with a price target of $0.40.
  • Vical, Inc. (NASDAQ: VICL) stock fell 2.0% to $0.88. The market cap seems to be at $16.2 million
 

Related Articles (ACST + APHA)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks Pre-Market MoversNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com